$425 Million is the total value of Ghost Tree Capital, LLC's 50 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 62.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QQQ | Buy | INVESCO QQQ TRput | $47,870,000 | +52.6% | 150,000 | +50.0% | 11.25% | +60.9% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $26,273,000 | -12.5% | 1,175,000 | -13.0% | 6.18% | -7.7% |
| TRILLIUM THERAPEUTICS INC | $20,943,000 | -27.0% | 1,950,000 | 0.0% | 4.92% | -23.0% | ||
| ARKG | New | ARK ETF TRput | $17,746,000 | – | 200,000 | +100.0% | 4.17% | – |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $17,399,000 | -0.6% | 135,000 | +28.6% | 4.09% | +4.8% |
| KURA | Buy | KURA ONCOLOGY INC | $16,962,000 | +59.8% | 600,000 | +84.6% | 3.99% | +68.6% |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $15,830,000 | -31.8% | 500,000 | 0.0% | 3.72% | -28.0% | |
| FATE | Buy | FATE THERAPEUTICS INC | $15,253,000 | +1.7% | 185,000 | +12.1% | 3.58% | +7.2% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $15,215,000 | +41.3% | 850,000 | +21.4% | 3.58% | +49.1% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $15,120,000 | +259.5% | 600,000 | -7.7% | 3.55% | +279.3% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $14,420,000 | -47.4% | 325,000 | -35.0% | 3.39% | -44.5% |
| COGT | Buy | COGENT BIOSCIENCES INC | $14,048,000 | +13.7% | 1,600,000 | +45.5% | 3.30% | +19.9% |
| ARVN | ARVINAS INC | $13,551,000 | -22.2% | 205,000 | 0.0% | 3.18% | -17.9% | |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $9,655,000 | -48.1% | 225,000 | -30.8% | 2.27% | -45.2% |
| TGTX | Sell | TG THERAPEUTICS INC | $9,640,000 | -25.9% | 200,000 | -20.0% | 2.27% | -21.8% |
| VTGN | Buy | VISTAGEN THERAPEUTICS INC | $8,826,000 | +86.4% | 4,143,702 | +69.8% | 2.07% | +96.6% |
| MRTX | MIRATI THERAPEUTICS INC | $8,565,000 | -22.0% | 50,000 | 0.0% | 2.01% | -17.7% | |
| VRNA | Buy | VERONA PHARMA PLCsponsored ads | $7,850,000 | +38.4% | 939,043 | +15.9% | 1.84% | +46.1% |
| ALDX | ALDEYRA THERAPEUTICS INC | $7,722,000 | +73.2% | 650,000 | 0.0% | 1.82% | +82.6% | |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $7,281,000 | -54.4% | 450,000 | -25.0% | 1.71% | -51.9% |
| ISEE | Sell | IVERIC BIO INC | $6,953,000 | -26.8% | 1,125,000 | -18.2% | 1.63% | -22.8% |
| IWM | New | ISHARES TRrussell 2000 etf | $6,628,000 | – | 30,000 | +100.0% | 1.56% | – |
| CNST | Sell | CONSTELLATION PHARMCETICLS I | $6,432,000 | -64.3% | 275,000 | -56.0% | 1.51% | -62.3% |
| BIIB | Buy | BIOGEN INC | $5,595,000 | +938.0% | 20,000 | +809.1% | 1.32% | +995.8% |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $5,150,000 | – | 250,000 | +100.0% | 1.21% | – |
| STSA | Buy | SATSUMA PHARMACEUTICALS INC | $5,136,000 | +457.0% | 904,225 | +352.1% | 1.21% | +488.8% |
| HLXA | HELIX ACQUISITION CORP | $5,118,000 | -10.0% | 500,000 | 0.0% | 1.20% | -5.1% | |
| EPIX | New | ESSA PHARMA INC | $5,084,000 | – | 175,000 | +100.0% | 1.20% | – |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $5,085,000 | -24.2% | 500,000 | -44.4% | 1.20% | -20.0% |
| CBIO | New | CATALYST BIOSCIENCES INC | $5,040,000 | – | 1,000,000 | +100.0% | 1.18% | – |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $5,013,000 | – | 300,000 | +100.0% | 1.18% | – |
| NUVB | New | NUVATION BIO INC | $4,964,000 | – | 500,000 | +100.0% | 1.17% | – |
| CRIS | CURIS INC | $4,811,000 | +38.2% | 425,000 | 0.0% | 1.13% | +45.7% | |
| BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $4,481,000 | – | 150,000 | +100.0% | 1.05% | – |
| FGEN | New | FIBROGEN INC | $4,339,000 | – | 125,000 | +100.0% | 1.02% | – |
| IMUX | IMMUNIC INC | $4,224,000 | +4.2% | 265,000 | 0.0% | 0.99% | +10.0% | |
| IMVT | Sell | IMMUNOVANT INC | $4,010,000 | -71.1% | 250,000 | -16.7% | 0.94% | -69.5% |
| SRRA | SIERRA ONCOLOGY INC | $3,446,000 | +7.5% | 200,000 | 0.0% | 0.81% | +13.4% | |
| NVAX | New | NOVAVAX INC | $3,173,000 | – | 17,500 | +100.0% | 0.75% | – |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $2,618,000 | -81.1% | 265,000 | -55.8% | 0.62% | -80.1% |
| KDMN | New | KADMON HLDGS INC | $2,334,000 | – | 600,000 | +100.0% | 0.55% | – |
| SAGE | New | SAGE THERAPEUTICS INC | $2,246,000 | – | 30,000 | +100.0% | 0.53% | – |
| CTIC | CTI BIOPHARMA CORP | $2,183,000 | -9.6% | 750,000 | 0.0% | 0.51% | -4.6% | |
| DTIL | New | PRECISION BIOSCIENCES INC | $2,070,000 | – | 200,000 | +100.0% | 0.49% | – |
| CLDX | New | CELLDEX THERAPEUTICS INC NEWput | $2,060,000 | – | 100,000 | +100.0% | 0.48% | – |
| CMRX | New | CHIMERIX INC | $1,928,000 | – | 200,000 | +100.0% | 0.45% | – |
| CASI | New | CASI PHARMACEUTICALS INC | $1,560,000 | – | 650,000 | +100.0% | 0.37% | – |
| APVO | APTEVO THERAPEUTICS INC | $1,526,000 | -16.7% | 50,000 | 0.0% | 0.36% | -12.0% | |
| OTIC | Buy | OTONOMY INC | $1,148,000 | -11.3% | 450,000 | +125.0% | 0.27% | -6.2% |
| FREQ | New | FREQUENCY THERAPEUTICS INCput | $950,000 | – | 100,000 | +100.0% | 0.22% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -200,000 | -100.0% | -0.35% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -400,000 | -100.0% | -0.44% | – |
| MLND | Exit | MILLENDO THERAPEUTICS INC | $0 | – | -925,000 | -100.0% | -0.44% | – |
| MRNA | Exit | MODERNA INCput | $0 | – | -35,000 | -100.0% | -0.82% | – |
| KALV | Exit | KALVISTA PHARMACEUTICALS INC | $0 | – | -200,000 | -100.0% | -0.85% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -40,000 | -100.0% | -1.52% | – |
| FPRX | Exit | FIVE PRIME THERAPEUTICS INC | $0 | – | -500,000 | -100.0% | -1.90% | – |
| SURF | Exit | SURFACE ONCOLOGY INC | $0 | – | -1,000,000 | -100.0% | -2.06% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INCcall | $0 | – | -50,000 | -100.0% | -2.45% | – |
| TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -475,000 | -100.0% | -2.88% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.